A detailed history of S.A. Mason LLC transactions in Novartis Ag stock. As of the latest transaction made, S.A. Mason LLC holds 4,040 shares of NVS stock, worth $430,017. This represents 0.24% of its overall portfolio holdings.

Number of Shares
4,040
Previous 4,240 4.72%
Holding current value
$430,017
Previous $428,000 8.88%
% of portfolio
0.24%
Previous 0.29%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$95.27 - $108.47 $19,054 - $21,694
-200 Reduced 4.72%
4,040 $390,000
Q1 2023

May 10, 2023

BUY
$80.03 - $92.81 $8,323 - $9,652
104 Added 2.51%
4,240 $390,000
Q3 2021

Oct 12, 2021

BUY
$81.78 - $95.14 $36,801 - $42,813
450 Added 12.21%
4,136 $338,000
Q3 2020

Oct 21, 2020

SELL
$82.14 - $91.0 $657 - $728
-8 Reduced 0.22%
3,686 $321,000
Q1 2020

May 14, 2020

SELL
$70.67 - $99.01 $9,328 - $13,069
-132 Reduced 3.45%
3,694 $305,000
Q4 2019

Jan 29, 2020

BUY
$84.35 - $95.37 $322,723 - $364,885
3,826 New
3,826 $362,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $229B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track S.A. Mason LLC Portfolio

Follow S.A. Mason LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of S.A. Mason LLC, based on Form 13F filings with the SEC.

News

Stay updated on S.A. Mason LLC with notifications on news.